Researchers at Mount Sinai and Memorial Sloan Kettering believe they’ve made a breakthrough in a new form of cancer treatment ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

Anthem Blue Cross Blue Shield and Memorial Sloan Kettering Cancer Center have reached a deal that keeps the premiere cancer treatment system in network, which helps patients maximize coverage.

U.S. Surgeon General Vivek Murthy issued a new report on alcohol and cancer, which emphasizes the risk of cancer in ...

NEW YORK--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield in New York and Memorial Sloan Kettering Cancer Center (MSK) announced today that the organizations have reached a new multi-year ...

Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), ...

Oncologist David Chung is taking on Northwell Health's newly established role of director of clinical research at its cancer ...

Ann Graham of MIB Agents discussed some of the challenges adolescent and young adult patients deal with after cancer ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of immunotherapy - ...

U.S. Surgeon General Vivek Murthy issued a new report on alcohol and cancer, which emphasizes the risk of cancer in ...